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Objective: Tissue degeneration reduces the durability of aortic and pulmonary
homograft heart valves. Homograft valves can evoke cellular and humoral immune
responses that might be detrimental to the valve tissue. Analyzing explanted
homograft valves helps in understanding the different factors that eventually lead to
tissue degeneration.
Methods: A total of 40 homografts was acquired from patients whose grafts had
been explanted because of stenosis (n  22), insufficiency (n  8), paravalvular
leakage (n  4), other technical problems (n  4), noncardiac death (n  1), and
stenosis with endocarditis (n  1). The period of implantation varied from 14 days
to 16 years (median, 4 years). Cryopreserved valves (n  31) were, in the majority,
derived from beating-heart donors, whereas the fresh valves were sterilized with
antibiotics and stored at 4°C for an average of 32 days. Four unimplanted cryopre-
served valves, 1 native aortic valve, and 1 native pulmonary valve were used as
references. Analysis included macroscopy, light microscopy with routine hematox-
ylin and eosin staining (cellularity and tissue structure), and immunohistochemical
studies to allow identification of macrophages (CD68) and T lymphocytes (CD3),
endothelial cells, leukocyte adhesion molecules (CD54, CD106, and CD62E), and
immunoglobulin (IgG) and complement factor (C3) depositions. In situ hybridiza-
tion for the Y chromosome was performed in 10 cases, with host-donor sex
mismatch, to distinguish between host and donor cells. The outcomes of histology
and immunohistochemistry were related to clinical factors, such as implantation
time and reason for explantation.
Results: In the first year after implantation, a strong reduction in cellularity of the
valve tissue was observed, with almost acellular tissues after 1 year. Trilaminar
tissue architecture disappeared with the same speed, whereas endothelial cells were
almost absent in all explants. Macrophages and T lymphocytes were encountered in
85% and 78% of the leaflets, respectively. Expression of leukocyte adhesion
molecules was low in almost all grafts, and IgG and C3 depositions were not
increased. Valve tissue cellularity consisted mainly of ingrown host cells when the
implantation time exceeded 1 year.
Conclusions: During the first year of implantation, homograft valves rapidly lose
their cellular components and normal tissue architecture. A low-grade inflammatory
response was observed, but no convincing evidence of immune-mediated injury was
found.
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The overall clinical performance of aortic andpulmonic homograft valves is good. Theirmain disadvantage is limited durability, es-pecially in young patients. Structural degen-eration of the valve tissue leads to graftdysfunction, and eventually reoperation is
needed.1-3
Current preservation techniques aim for a high degree of
cellular viability at the time the graft is implanted. Previous
research indicates that donor cells seem to disappear rapidly
and will, in part, be replaced by host cells.4,5 Furthermore,
it is known that cryopreserved valves are capable of evoking
cellular and humoral immune responses in vitro and in
vivo.6,7 It is uncertain, however, whether the immunogenic-
ity of these valves contributes to the loss of valve cellularity
and structure and thereby to their dysfunction and failure. In
addition to this, other determinants of homograft failure are
known, such as high donor age and donor age higher than
patient age.2
In a series of 40 explanted homograft valves, the extent
of donor-cell survival was assessed, as was the significance
of host-cell ingrowth, with the use of in situ hybridization
for the Y chromosome. Immunohistochemistry was per-
formed for analysis of inflammatory cell infiltration.
Searching for indicators of immune-mediated injury, ex-
pression of leukocyte adhesion molecules and immunoglob-
ulin and complement depositions were measured with the
use of monoclonal antibodies. The outcomes of histologic
analysis were related to clinical factors to elucidate ho-
mograft pathology.
Materials and Methods
We examined 31 cryopreserved and 9 fresh homograft heart valves
that had been implanted for periods ranging from 2 weeks to 16
years; the median implantation time was 4 years. Reasons for
explantation were stenosis (n  22), insufficiency (n  8), para-
valvular leakage (n  4), other technical problems (eg, external
compression; n  4), noncardiac death (n  1), and stenosis with
endocarditis (n  1). Ten aortic homografts had been implanted in
the left ventricular outflow tract, and 13 aortic valves had been
implanted in the right ventricular outflow tract (RVOT), whereas 3
pulmonic valves had been implanted in the left ventricular outflow
tract and 14 in the RVOT. Mean donor age was 26 years (range,
0.5-55 years; median, 27 years), and mean recipient age was 18
years (range, 0.1-61 years; median, 16 years). The cryopreserved
valves were primarily derived from beating-heart donors (n  28)
with no or very short warm ischemic times (1 hour); the remain-
ing 3 valves, derived from non–beating-heart donors, had warm
ischemic times of less than 6 hours. Twenty-two of these valves
were cryopreserved with dimethylsulfoxide 10% as a cryoprotec-
tive agent, and 9 were cryopreserved with glycerol. Eighteen
cryopreserved valves were sterilized in a low-dose antibiotic so-
lution, and 13 were not. Eight of the 9 fresh valves had warm
ischemic times of less than 6 hours and were all antibiotically
sterilized for 24 hours, after which they were stored at 4°C in a
tissue culture medium for 28 to 95 days (mean, 32 days). On one
fresh valve, no additional information was available. All ho-
mograft explants were collected over a period of 4 years (1994-
1998). The fresh valves were all implanted in the early 1980s, and
therefore were, per definition, late failures. The cryopreserved
valves were implanted in the late 1980s and early 1990s. Four
unimplanted cryopreserved valves (2 aortic and 2 pulmonary
valves) and 2 native valves acquired at autopsy (1 aortic and 1
pulmonary valve) served as references.
The homograft explants were transported in tissue culture me-
dium TC 199 in a polystyrene box containing melting ice. The
valves were macroscopically examined and then prepared for
histologic examination. Each homograft was partially frozen, par-
tially formalin fixed, and sequentially paraffin embedded. Thus
each part contained a radial section of leaflet tissue, preferably
together with aortic or pulmonary arterial wall tissue. In 1 case
only the arterial wall tissue was available, whereas in 5 cases only
leaflet tissue was explanted. Paraffin sections were stained with
hematoxylin-and-eosin (H&E) by using routine methods. The
other tissue blocks were embedded in Tissue-Tek OCT Compound
(Sakura Finetek, Torrana, Calif) and packed in small plastic bags.
After proper orientation of the tissue block, the bags were heat
sealed and transferred to a tube containing cold isopentane, which
was then submersed in liquid nitrogen for 30 seconds. The spec-
imens were stored at 70°C until they were cut. Radial 4- and
8-m sections were cut from each frozen graft with a Reichert-
Jung 2800 Frigocut cryostat (Leica Instruments GmbH, Nussloch,
Germany). Sections were put on Starfrost gelatin-precoated slides
(Knittel Gla¨ser, Braunschweig, Germany) to reduce the risk of
section detachment. The sections were air-dried for at least 60
minutes to improve tissue adherence. The slides were then stored
at 20°C until further use.
Analysis of the tissue included gross macroscopic inspection,
light microscopy to examine cellularity and tissue structure, and
immunohistochemical studies to allow for identification of mac-
rophages, T lymphocytes, and endothelial cells and expression of
leukocyte adhesion molecules (CD54, CD106, and CD62E) and
immunoglobulin (IgG) and complement factor (C3) depositions.
Ten valves with sex mismatch between the donor and the recipient
were used for the in situ hybridization procedure. With the use of
a biotin-labeled DNA probe for the Y chromosome, distinction
could be made between male and female cells and thereby between
host and donor cells in radial tissue sections. The methodology of
this technique has been described in detail previously.5,8
Microscopy
All sections were evaluated without prior knowledge of clinical
information. Immunoperoxidase-stained sections and H&E-
stained sections were examined by using light microscopy, and
observations were processed in a semiquantitative manner. For
cellularity of the valve vessel wall and the valve leaflet, the amount
of morphologically intact cellular elements was scored, taking into
account cell density and distribution pattern throughout the whole
tissue section. Complete acellular tissue was scored as 0, whereas
a score of 3 referred to the normal cellularity, as observed in the
reference tissue samples. Three other categories were distin-
guished: 1, strongly diminished cellularity; 2, diminished cellular-
ity; and 4, increased cellularity. Tissue structure was scored as 0
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when trilaminar architecture was not recognizable, 1 when it was
blurred, and 2 when it was normally present.
Immunohistochemistry and In Situ Hybridization
The monoclonal antibodies used for the detection of infiltrating
inflammatory cells were KP-1 (IgG1, kappa; Dako, Carpenteria,
Calif)9 and UCHT-1 (IgG1, kappa; Dako).10 They were directed
against monocytes and macrophages (anti-CD68) and T lympho-
cytes (anti-CD3), respectively. Expression of leukocyte adhesion
molecules was detected by using monoclonal antibodies against
CD54 (intercellular adhesion molecule [ICAM]), CD106 (vascular
cell adhesion molecule [VCAM]), and CD62E (E-selectin). A
specific monoclonal antibody for endothelial cells was used
(PAL-E; Pathology Department, Leiden University Medical Cen-
ter, Leiden, The Netherlands). Anti-mouse IgG-FITC (Nordic Im-
munology, Tilburg, The Netherlands) and anti-complement factor
C3c-FITC (Dako) were used to detect IgG and C3 depositions. The
Y chromosome–specific, biotin-16dUTP–labeled probe used for in
situ hybridization was DYZ-3 (Amersham International, Amer-
sham, United Kingdom). For evaluation of the anti-IgG and anti-
C3c stainings and the in situ hybridization material, a Leitz Di-
aplan fluorescence microscope was used with an HBO 100 W
vapour mercury lamp and Leitz filters A and K3 (Ernst Leitz,
Wetzlar GmbH, Wetzlar, Germany). Inflammatory cells, expres-
sion of leukocyte adhesion molecules, and IgG and C3 depositions
were scored according to their distribution pattern in the tissue: 0,
absent; 1, focal appearance or weakly positive; 2, multifocal; 3,
diffuse; and 4, diffuse and strongly positive.
Statistical Analysis
Homograft explants were divided into 5 groups according to their
implantation time: (1) less than 1 year; (2) 1 to 3 years; (3) 3 to 5
years; (4) 5 to 10 years; and (5) greater than 10 years. For both
arterial wall and leaflet tissue samples, mean scores for cellularity,
tissue structure, macrophages, T lymphocytes, leukocyte adhesion
molecules, and immunoglobulin and complement factor deposi-
tions were calculated per implantation time group and compared
with the corresponding mean scores for the 6 reference wall and
leaflet tissue samples. Significance of differences in mean scores
between implantation time groups and the reference group was
tested with the Mann-Whitney U test. Because of the small num-
bers, exact P values (2-sided tests) were computed (SPSS soft-
ware; SPSS Inc, Chicago, Ill).
Results
Macroscopy
All grafts explanted for stenosis, insufficiency, or both
showed evident pathologic changes. In most cases leaflets
were slightly thickened and had lost their transparent ap-
pearance. In case of valvular leakage, the cusps were often
thicker and retracted. In case of stenosis, the wall was often
heavily calcified, especially the conduit in the RVOT in
children. In adults calcifications were mainly seen in the
arterial wall when implantation time was greater than 10
years. In 7 cases with an implantation time exceeding 5
Figure 1. Photomicrograph of radial sections of an unimplanted cryopreserved aortic valve and midterm explant.
(Routine H&E staining; original magnification 250.) A, Unimplanted cryopreserved aortic homograft valve. Note
the carefully arranged collagen bundles and rippled outflow surface as an expression of leaflet elasticity. B,
Cryopreserved aortic homograft from a beating-heart donor implanted in a 20-year-old woman in the RVOT and
explanted after 2.5 years because of stenosis caused by thickening of the vessel wall. The leaflet shows the typical
loss of tissue architecture and cellular elements, stretching of collagen (loss of elasticity), and increase in
ground-substance volume.
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years, some focal calcifications were observed in the leaflet
tissue.
Light Microscopy
An intimal layer could be distinguished in the arterial wall
of the homograft in none of the cases, whereas from the
adventitia, only some remnants were found at the host-
donor interface. In 60% of the grafts, fibrous sheating was
observed on the arterial wall, and in 40% it extended onto
the proximal third part of the leaflet. Figure 1 shows the
typical appearance of a leaflet explanted after more than 1
year (implantation time, 2.5 years). The carefully arranged
collagen bundles in the leaflet had changed into an amor-
phous mass with an increase in ground-substance volume.
As shown in Figure 2, most tissue samples showed
strongly reduced cellularity or were acellular when ex-
planted after more than 1 year. For arterial wall tissue
samples, mean cellularity was significantly reduced, even
with implantation times of less than 1 year (P  .01). The
reductions were also significant for the 4 other implantation
time groups (1-3 years, P  .001; 3-5 years, P  .001; 5-10
years, P .001; and10 years, P .004). For leaflet tissue
samples, a significant decrease in mean cellularity was
found for the 4 groups with implantation times of greater
than 1 year (1-3 years, P  .001; 3-5 years, P  .001; 5-10
years, P  .001; and 10 years, P  .002).
In Figure 3 leaflet tissue samples explanted because of
stenosis or insufficiency are referred to as being explanted
because of degeneration, whereas grafts explanted because
of paravalvular leakage, external compression, or noncar-
diac death are referred to as being explanted for technical
reasons. With implantation times of less than 1 year, mean
cellularity in the leaflet tissue samples was normal when
explanted for technical reasons (n  5). In fact, 2 grafts
(explanted after 5 and 6 months, respectively) showed in-
creased cellularity caused by influx of inflammatory cells, 1
graft (explanted after 2 weeks) showed normal cellularity,
and 2 grafts (explanted after 2 weeks and 2 months, respec-
tively) showed reduced cellularity. The single graft ex-
planted because of degeneration within 1 year (implantation
time of 6 months) showed acellular tissue. Combining all
leaflet tissue samples explanted after 1 year, mean cellular-
ity in both grafts explanted for technical reasons (n 4) and
grafts explanted because of degeneration (n  28) was
significantly reduced compared with that of the reference
leaflet tissues (P  .01 and P  .001, respectively).
Mean trilaminar tissue structure in tissue samples was
also significantly reduced with implantation times of greater
than 1 year (1-3 years, P  .001 and P  .001 for arterial
wall and leaflet tissue samples, respectively; 3-5 years, P
.001 and P .001, respectively; 5-10 years, P .001 and
Figure 2. Mean cellularity for both arterial wall and leaflet tissue samples of unimplanted and explanted
homografts. Explanted homografts are grouped according to their implantation time.
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P  .002, respectively; and 10 years, P  .004 and P 
.002, respectively). Figure 4 shows mean trilaminar tissue
structure in the leaflet implantation time groups differenti-
ated according to reason for explantation. For homografts
explanted for technical reasons within 1 year (n  5),
trilaminar architecture was normal in 2 grafts and blurred in
3 grafts. In the single graft explanted because of degenera-
tion within 1 year, normal tissue structure was not recog-
nizable. Combining leaflet tissue samples with implantation
times of greater than 1 year, trilaminar architecture was
almost not recognizable and significantly reduced in grafts
explanted because of degeneration (P .001), whereas in
grafts explanted for technical reasons, the reduction was
smaller and not significant (P  .07).
Immunohistochemistry
In grafts with implantation times of less than 1 year, inflam-
matory cells were predominantly localized in the leaflets,
especially in the hinge area and covering fibrous sheaths,
and were diffusely distributed (Figure 5). In grafts with
implantation times of greater than 1 year, inflammatory
cells showed a preference for the adventitial side of the
arterial wall in the area of the host-donor interface and were
seen in small groups. The inflammatory infiltration seen in
most grafts contained no neutrophil granulocytes.
Figure 6 shows that in the wall tissue samples the mean
amount of macrophages was significantly increased with
implantation times of less than 1 year (P  .03), whereas a
significant increase in T lymphocytes occurred later. Sig-
nificant increases in macrophages were also found for the
implantation time groups of 1 to 3 years and 3 to 5 years
(P  .04 and P  .006, respectively). Significant increases
in T lymphocytes were found for the implantation time
groups of 1 to 3 years and 3 to 5 years (P  .04 and P 
.01, respectively). For the leaflet implantation time groups,
no significant increases in the amounts of macrophages and
T lymphocytes were found, yet macrophages and T lym-
phocytes were encountered in 85% and 78% of the exam-
ined leaflets, respectively.
A monolayer of cells covering some part of the wall and
leaflet surface was seen in 30% of the examined specimens
by using routine H&E staining. Specific staining with
PAL-E showed endothelial cells to some extent (multifocal
appearance or 50% of the surface covered) in only 2
valves (explanted after 5 and 59 months, respectively). The
remaining valves showed no or only focal positivity for the
PAL-E staining. The cryopreserved valves from the refer-
ence group showed heavily damaged endothelium. Capil-
lary vessels at the host-donor interface often served as an
Figure 3. Mean cellularity for leaflet tissue samples. Explanted grafts are grouped according to implantation time
and reason for explantation. Within the implantation time groups of 3 to 5 years and greater than 10 years, no
homografts were explanted for technical reasons. One valve in the implantation group of greater than 10 years was
explanted because of endocarditis.
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internal positive control, being strongly positive with
PAL-E.
Expression of leukocyte adhesion molecules (ICAM,
VCAM, and E-selectin) in the explanted wall tissue samples
was not significantly increased compared with that in the
reference wall tissues. For leaflet tissue samples, significant
increases in ICAM were found for 2 implantation time
groups: less than 1 year (P  .02) and 5 to 10 years (P 
.02). The valve with endocarditis was strongly positive. No
relation with ABO blood group match or mismatch was
found.
Depositions of IgG and C3 were not significantly in-
creased compared with those in the reference wall and
leaflet tissues, showed only a slightly positive reaction at the
basal membranes, and could not be related to ABO blood
group match or mismatch.
In Situ Hybridization
The results of this analysis have been described extensively
in a previous article,5 and therefore we limit ourselves to a
summary of the results. The homograft arterial wall was
occupied by a vast majority of penetrating host fibroblasts in
8 of 10 examined specimens, whereas the donor fibroblasts
had disappeared almost completely at that site. In 7 cases
host-cell and donor-cell populations were found to coexist
in the aortic wall, and in 5 grafts they also coexisted in the
leaflets. In 3 grafts only host cells were identified, although
strongly decreased in number and with unequal distribution.
Discussion
From our findings, part of which have been reported earli-
er,5 conclusions can be drawn with respect to the origin and
fate of cellular elements in cryopreserved and fresh-stored
homografts. A comparison between cryopreserved and fresh
valves with regard to possible differences in donor-cell
survival and other pathologic changes was not conducted
because the fresh valves were implanted during an earlier
time period than the cryopreserved valves and had longer
implantation times.
In this series of 40 clinical explants, overall cellularity
was found to decrease strongly in the first year after im-
plantation, with almost acellular tissues after 1 year. The
results of the in situ hybridization procedure revealed that in
all grafts examined with this technique, host cells were
present, whereas donor-cell populations were strongly re-
duced or even absent. There are no reasons to believe that
this phenomenon is limited to cases of sex mismatch be-
tween host and donor. Thus donor-cell survival is even less
than regular cell counting suggests because in most valves
both host and donor cells might be assumed to be present.
Figure 4. Mean trilaminar structure for leaflet tissue samples. Explanted grafts are grouped according to
implantation time and reason for explantation. Within the implantation groups of 3 to 5 years and greater than 10
years, no homografts were explanted for technical reasons. One valve in the implantation group of greater than 10
years was explanted because of endocarditis.
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Host-cell ingrowth seemed to have no significant mean-
ing with regard to the maintenance of valve tissue structure
because the number of the ingrown cells was limited, espe-
cially in the leaflets, all the more so because a substantial
part of the ingrown host cells consisted of inflammatory
cells.
In valves explanted for technical reasons, donor-cell
survival was poor as well. In homografts explanted after 1
year, both grafts explanted for technical reasons and grafts
explanted because of degeneration showed the same reduc-
tion in cellularity. Loss of trilaminar tissue architecture was
also observed in grafts explanted for technical reasons after
1 year, although to a lesser extent than in grafts explanted
because of degeneration. Probably, for reasons unknown,
preservation of the extracellular matrix compounds in the
valves explanted for technical reasons was better and, at
least to a certain degree, independent from functioning
connective tissue cells.
In other homograft explant studies,11,12 early loss of
cellular elements and tissue architecture has been observed
as well. On the basis of these observations, it was concluded
that the overall acceptable performance of cryopreserved
homografts is mainly a result of the (relatively good) pres-
ervation of the collagenous skeleton and other compounds
of the extracellular matrix, a statement supported by the
observations described above. In these studies no evidence
of immune-mediated injury was found.
In our series influx of macrophages and T lymphocytes
was observed in almost all homografts, whereas, on the
other hand, donor cells had disappeared and tissue structure
had deteriorated. Especially in proportion to donor-cell
presence, this inflammatory infiltrate is considered to be of
some significance, although it was certainly less than has
been observed in cases of acute organ rejection.11 The early
influx of macrophages that preceded T-cell influx indicates
that these cells might have been recruited to remove cell
debris. However, their potential involvement in the dramatic
reduction of cell numbers remains to be established.
No persistent upregulation of leukocyte adhesion mole-
cules was observed, which would have been a strong indi-
cator of immune-mediated injury. Still, the possibility exists
that immune-mediated injury developed in an earlier phase
of implantation, after which the immune reaction faded
away, as reflected by an early but transient expression of
ICAM in leaflet tissue samples of homografts that had been
explanted within the first year. On the other hand, the
absence of neutrophil granulocytes and antibody and com-
plement depositions and the late influx of T lymphocytes are
all indicators that the reduction in cell number is mediated
by the process of apoptosis13 rather than by necrosis after
immune-mediated injury. The process of apoptosis itself,
however, can be induced by donor-specific antibodies, as
demonstrated in vitro and in vivo in a recent study.14 In
Figure 5. Photomicrograph of radial sections of a cryopreserved
aortic valve homograft harvested from a beating-heart donor (age,
48 years). The graft was used as aortic valve replacement in a
30-year-old woman and explanted after 2 weeks because of
paravalvular leakage (without any sings of endocarditis). A, H&E
staining of the hinge area of the valve, with the sinus wall (W) on
the right and the proximal part of the cusp on the left. (Original
magnification 250.) B, Immunohistochemistry of the same area
with monoclonal antibodies directed against monocytes and
macrophages (anti-CD68). The infiltration of inflammatory cells in
the hinge area is clearly demonstrated. (Dark-brown coloring of
immunoperoxidase; original magnification 250.) C, Detail of the
aortic site of the hinge area in which infiltration of T lymphocytes
in the intimal layer is demonstrated with anti-CD3 monoclonal
antibodies.
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addition, several other studies have testified that homograft
tissue is antigenic and immunogenic.6,7,15-17
The presence of endothelial cells in explanted grafts was
negligible. In the valves used as a reference, the harvesting
and cryopreservation procedure had resulted in loss of en-
dothelium because even these unimplanted cryopreserved
valves showed a very limited number of endothelial cells.
Our observations indicate that the capacity of donor endo-
thelial cells to regenerate after implantation is low or absent
and that host endothelial cells do not replace it.
Early loss of endothelium renders the homograft less
antigenic,18,19 whereas, on the other hand, it might lead to
influx of proteins and subsequent alterations in the extra-
cellular matrix, such as atherosclerotic changes. Indeed,
some important features of atherosclerotic disease can be
observed in homograft explants, such as dysfunction (ab-
sence) of endothelium, inflammatory lesions consisting of
macrophages and T lymphocytes, and stenosis with calcifi-
cation.20 Furthermore, changes in extracellular matrix com-
pounds, hypoxia, and humoral injury might contribute to the
induction of apoptotic cell death.13,14
In this series the survival of cellular elements of ho-
mografts was poor, and thereby their contribution to valve
structure and function is considered to be minimal as well.
Therefore the question remains whether it is reasonable to
implant a viable tissue valve and, moreover, whether it is
desirable to do so with at least the possibility of an immune
reaction with adverse effects on its tissue structure.
References
1. O’Brien MF, Harrocks F, Stafford EG, Gardner MAH, Pohlner PG,
Tesar PJ, et al. The homograft aortic valve: a 29-year, 99.3% fol-
low-up of 1,022 valve replacements. J Heart Valve Dis. 2001;10:334-
45.
2. Lund O, Chandrasekaran V, Grocott-Mason R, Elwidaa H, Mazhar R,
Kaghaghani A, et al. Primary aortic valve replacement with allografts
over twenty-five years: valve-related and procedure-related determi-
nants of outcome. J Thorac Cardiovasc Surg. 1999;117:77-91.
3. Clarke DR, Campbell DN, Hayward AR. Degeneration of aortic valve
allografts in young recipients. J Thorac Cardiovasc Surg. 1993;105:
934-42.
4. Hazekamp MG, Koolbergen DR, Braun J, Sugihara H, Cornelisse CJ,
Goffin YA, et al. In situ hybridization: a new technique to determine
the origin of fibroblasts in cryopreserved aortic homograft valve
explants. J Thorac Cardiovasc Surg. 1995;110:248-57.
5. Koolbergen DR, Hazekamp MG, Kurvers M, de Heer, Cornelisse CJ,
Huysmans HA, et al. Tissue chimerism in cryopreserved homograft
valve explants demonstrated by in situ hybridization. Ann Thorac
Surg. 1998;66:S225-32.
6. Hoekstra FME, Knoop CJ, Jutte NHPM, Wassenaar C, Mochtar B,
Bos E, et al. Effect of cryopreservation and HLA-DR matching on the
cellular immunogenicity of human cardiac valve allografts. J Heart
Lung Transplant. 1994;13:1095-8.
7. Hoekstra FME, Knoop CJ, Vaessen LMB, Wassenaar C, Jutte NHPM,
Bos E, et al. Donor-specific immune response against human cardiac
valve allograft. J Thorac Cardiovasc Surg. 1996;112:281-6.
8. Braun J, Hazekamp MG, Koolbergen DR, Sugihara H, Goffin YA,
Huysmans HA, et al. Identification of host and donor cells in porcine
Figure 6. Mean influx of inflammatory cells (macrophages and T lymphocytes) in wall tissue samples. Explanted
grafts are grouped according to implantation time.
Surgery for Acquired Cardiovascular Disease Koolbergen et al
696 The Journal of Thoracic and Cardiovascular Surgery ● October 2002
A
CD
homograft heart valve explants by in situ hybridization, J Pathol.
1997;183:99-104
9. Pulford KAF, Rigney EM, Micklem KJ, Jones M, Stross WP, Gatter
KC, et al. KP-1: a new monoclonal antibody that detects a monocyte/
macrophage associated antigen in routinely processed tissue sections.
J Clin Pathol. 1989;42:414-21.
10. Beverly PCL, Callard RE. Distinctive functional characteristics of
human T-lymphocytes defined by E rosetting or a monoclonal anti-T
cell antibody. Eur J Immunol. 1981;11:329-34.
11. Mitchell RN, Jonas RA, Schoen FJ. Pathology of explanted cryopre-
served allograft heart valves: comparison with aortic valves from
orthoptic heart transplants. J Thorac Cardiovasc Surg. 1998;115:118-
28.
12. Mitchell RN, Jonas RA, Schoen FJ. Structure-function correlations in
cryopreserved allograft valves. Ann Thorac Surg. 1995;60:S108-13.
13. Hilbert SL, Luna RE, Zhang J, Wang Y, Hopkins RA, Yu Z, et al.
Allograft heart valves: the role of apoptosis-mediated cell loss. J Tho-
rac Cardiovasc Surg. 1999;117:454-62.
14. Plissonier D, Henaff M, Poncet P, Paris E, Tron F, Thuillez C.
Involvement of antibody-dependent apoptosis in graft rejection.
Transplantation. 2000;69:2601-8.
15. Rajani B, Mee RB, Ratliff NB. Evidence for rejection of homograft
cardiac valves in infants. J Thorac Cardiovasc Surg. 1998;115:111-7.
16. Gonzales-Lavin L, Bianchi J, Graf D, Amini S, Gordon GL. Degen-
erative changes in fresh aortic root homografts in a canine model:
Evidence of an immunologic influence. Transplant Proc. 1988;
20(Suppl 1):815-9.
17. Salomon RN, Friedman GB, Callow AD, Payne DD, Libby P. Cryo-
preserved homografts contain viable smooth muscle cells capable of
expressing transplantation antigens. J Thorac Cardiovasc Surg. 1993;
106:1173-80.
18. Lupinetti FM, Tsai TT, Kneebone JM, Bove EL. Effect of cryopreser-
vation on the presence of endothelial cells on human valve allografts.
J Thorac Cardiovasc Surg. 1993;106:912-7.
19. El Khatib H, Thompson SA, Lupinetti FM. Effect of storage at 4
degrees Celcius in a nutrient medium on antigenic proporties of rat
aortic valve allografts. Ann Thorac Surg. 1990;49:792-6.
20. Ross R. Atherosclerosis–an inflammatory disease. N Engl J Med.
1999;340:115-26.
Koolbergen et al Surgery for Acquired Cardiovascular Disease
The Journal of Thoracic and Cardiovascular Surgery ● Volume 124, Number 4 697
A
CD
